每日使用葡萄糖酸洗必泰抗菌沐浴的意义
- 格式:pdf
- 大小:321.18 KB
- 文档页数:5
皮肤医用抗菌敷料(喜美健)使用说明书包装规格:30ml适用范围:适用于人体体表、小面积皮肤和粘膜创面感染的预防及辅助治疗。
用法用量:1、用于头部、脐部、肢体皮肤、手足部位皮肤杀菌、皮肤新鲜破裂等使用时:用本品直喷患部,日喷3~5次,症愈即可停用。
2、用于各种原因引起的皮肤感染时:用本品直喷患部,日喷3~5次。
3、用于阴道、肛门皮肤感染时:用本品直喷患部,日喷3~5次,症愈即可停用;或取本产品适量按1:4的比例用凉开水稀释后冲洗。
4、用于口腔感染或口腔溃疡时:用本品对准口腔患处均匀喷洒,含漱作用5分钟后吐出,用清水漱口即可。
5、用于创伤、烧伤、烫伤、褥疮、溃疡、伤口及粘膜的感染时:用本品直喷患部,日喷3~5次,症愈即可停用。
6、用于儿童皮肤感染时:用本品直喷患部,日喷2~3次,症愈即可停用。
7、炎症消失后建议继续使用本品一周左右,以巩固疗效。
注意事项:1、内装外用杀菌制剂,不得口服。
置于儿童不宜触及处。
2、请在医生指导下使用,若对粘膜使用过量时,可能出现后、粘膜红肿现象,应停用并咨询医生。
3、避免与有机物和拮抗药同时使用(如肥皂等阴离子洗涤剂、碘或过氧化物),以免影响疗效。
4、对本品双烷基季铵盐、甘油、薄荷等成分过敏者忌用。
贮存:在相对湿度不超过80%且无腐蚀性物质、通风良好的室内,密封,置阴凉干燥处保存。
伊洁士牌75%消毒酒精产品说明:主要成分为乙醇,含量为73%-77%,可杀灭肠道致病菌、化脓性球菌、致病性酵母菌和医院感染常见细菌。
使用范围:适用于手术和注射部位的皮肤消毒。
使用方法:用无菌棉签或棉球直接蘸取本品原液涂擦皮肤作用2分钟。
注意事项:为外用消毒液,不得口服;不能用于外科器械消毒;乙醇过敏者慎用;置于阴凉、通风、干燥处保存;易燃,远离火源。
伊洁士牌95%酒精使用方法:1、先用蒸馏水将本品稀释至75%后使用。
2、燃烧可直接使用。
注意事项:1、乙醇过敏者慎用;2、置于阴凉、通风、干燥处保存;3、易燃,远离火源。
3种常用龈下冲洗液治疗慢性牙周炎的牙周指数比较古贝妮【摘要】目的:研究双氧水与生理盐水、替硝唑液、复方氯己定液(口泰液)作为龈下冲洗液治疗慢性牙周炎的牙周指数变化.方法:将90名患者(90颗患牙)随机分成双氧水生理盐水组、替硝唑液组和口泰液组,每组各30例患者30颗患牙,治疗前与治疗后6周分别取样,进行牙周指数分析.结果:替硝唑液组与口泰液组牙周指数变化有显著性差异(P<0.05),双氧水生理盐水组牙周指数变化程度无显著性差异(P>0.05).结论:替硝唑与口泰液为有抗菌成分的龈下冲洗液,能显著改善牙周组织的炎症状态.【期刊名称】《现代临床医学》【年(卷),期】2012(038)001【总页数】2页(P61-62)【关键词】慢性牙周炎;牙周指数;龈下冲洗【作者】古贝妮【作者单位】成都铁路分局医院,四川成都610081【正文语种】中文【中图分类】R718.4+2能否有效改善慢性牙周炎牙周指数,是判断牙周炎临床治疗效果的重要标志。
双氧水与生理盐水、替硝唑液、复方氯己定液(口泰液)均是在临床上广泛应用的龈下冲洗液。
2010年8月至2011年3月,笔者以3种冲洗液用于90例患者,对治疗前和治疗后6周的牙周指数各项,包括牙龈指数(GI)、牙周指数(DI)、牙石指数(CI)、菌斑指数(PLI)、牙龈沟出血指数(SBI)、牙周袋深度(PD)进行对比,以期为临床选择理想的牙周龈下冲洗液提供依据。
1 材料与方法1.1 一般资料慢性牙周炎患者90例,共90颗患牙,其中:男44例,女46例;年龄21~47岁。
患者无全身系统性疾病,临床无明显全身反应,张口受限Ⅰ°,近2月来未接受任何抗生素治疗。
将90例患者随机分成双氧水生理盐水组、替硝唑液组和口泰液组,每组各30例患者30颗患牙。
3组病例性别、年龄、病程、病情无显著性差异(P>0.05),具有可比性。
1.2 材料生理盐水和3%双氧水均由四川科伦药业股份有限公司生产,替硝唑液由四川华天科技有限公司生产,0.2%口泰液由深圳南粤药业有限公司生产。
2%葡萄糖洗必泰擦浴在骨科术前皮肤清洁消毒的应用研究作者:李会霞任达魏寒松任菊祥崔艳玲来源:《医学信息》2016年第20期摘要:目的探讨2%葡萄糖洗必泰擦浴在骨科无菌手术切口感染预防的应用,研究不同皮肤准备方式对骨科术后感染发生的影响,论证骨科术前简化备皮方式的可行性。
方法将纳入标准的患者160例,分别为实验组和对照组。
其中实验组120例,再按每组40例随机分为3组,分别为:实验A手术日晨+术前连续二晚皮肤准备;实验B手术日晨+术前晚皮肤准备;实验C手术日晨皮肤准备;观察组40例采用传统剃毛备皮法。
结果对照组发生切口感染3例(7.5%)发生皮疹4例(10%),实验组未发生切口感染及皮疹.两组的切口感染率及皮疹的比较(P关键词:洗必泰;骨科无菌手术;清洁消毒;感染预防手术切口感染是外科最常见并发症之一,在美国每年大约有780000病例的手术发生感染,平均可延长住院时间7.4d,每伤口感染平均花费医疗400~2600美元,外科手术切口感染(SSI)被美国CDC认为是手术患者最常见的不良事件。
吴安华等[1]对我国193所医院的调查显示,SSI居医院感染的第3位,黄文英等[2]调查发现每一个手术切口感染的发生,平均延长住院12d,额外增加治疗费用12872元。
如何有效预防院内感染对于骨科手术意义重大。
现将2%葡萄糖洗必泰消毒液全身沐浴用于骨科无菌手术术前皮肤准备的研究结果报道如下。
1资料与方法1.1一般资料入住骨科拟行择期手术的患者。
纳入标准:入住骨科病房择期行无菌手术的所有患者。
排除标准:入院后24h内急诊手术患者,入院时有开放性伤口或有皮肤损伤的患者,入院时确诊或拟疑似感染的患者,有沟通障碍依从性差如精神异常、老年性痴呆等患者。
1.2研究方法1.2.1分组情况将入住骨科并符合纳入标准的患者160例,采用单盲法按入院顺序随机分为4组,分别为实验组A,B,C和对照组。
其中实验组120例均使用2%葡萄糖洗必泰(2%CHG)皮肤消毒液沐浴,分别为:实验A 于手术日晨+术前连续二晚皮肤准备;实验B 手术日晨+术前晚皮肤准备,实验C 手术日晨皮肤准备;对照组40例采用传统教科书要求备皮方式进行术前连续二晚+手术日晨皮肤准备。
普外科I类切口手术部位感染危险因素探究与防控对策目的:对我院普外科2013年I类切口手术病例资料进行回顾性分析,探讨普外科I类切口手术部位感染的危险因素,总结临床防控对策。
方法:对2013年1月至12月482例普外科I类切口手术病例进行回顾性分析,探讨手术部位感染的危险因素及防控措施。
结果:高龄(≥60岁)、术前住院时间长(>3 d)及手术时间(≥2 h)为普外科一类切口手术部位感染的独立危险因素。
结论:对普外科I类切口手术患者应重视对高龄、术前住院时间长、手术时间等高危因素的监控,提高医师手术技巧,严格执行无菌技术操作规范,以降低感染率。
标签:手术部位感染;危险因素;防控对策手术部位感染是指围手术期发生在切口或手术深部器官(或腔隙)的感染,是常见的医院感染之一,占医院感染的10%—19%,不仅给病人带来痛苦,而且造成巨大的经济损失[1]。
切口感染后,平均延长住院日10天;重者导致手术失败乃至死亡,外科医师必须倍加重视[2]。
我们通过对2013年普外科I类切口手术部位感染病例资料进行分析,探讨手术部位感染的危险因素,为采取有效干预措施,控制手术部位感染提供依据。
1 资料与方法1.1 资料来源收集某院普外科2013年1月—12月间482份I类切口手术患者资料,查阅手术记录单、体温单、病程记录、医嘱单、各种辅助检查单、切口分泌物培养结果等,确定有无感染,并使用统一调查表逐项登记。
1.2 诊断标准按照卫生部2001年颁布的《医院感染诊断标准(试行)》诊断医院手术部位感染。
1.3 统计学分析数据处理应用统计学软件SPSS13.0,相关因素分析应用卡方检验,当P<0.05表示数据间比较具有统计学意义。
2 结果2.1 手术部位感染率共调查普外科482例I类切口手术患者病历,发现手术部位感染9例,9例次,切口感染发生率为1.87%,例次感染率为1.87%。
其中表浅切口感染6例次(66.67%),深部切口感染3例次(33.33%),器官腔隙感染例次0。
感控精粹|关于氯已定(洗必泰)与氯已定醇的循证及相关规范标准氯己定(俗称洗必泰) (chlorhexidine) 属胍类消毒剂,问世于上世纪50年代初。
此类消毒剂对细菌繁殖体以及部分病毒和真菌都具有很好的杀灭效果, 其无不良气味, 刺激性小, 使用者可接受性强。
近年来,氯已定广泛应用于皮肤、黏膜、导管接头等方面的消毒,对降低院内感染起了很大的作用。
本文探讨葡萄糖酸氯已定(CHG) 在重症病人全身擦浴及导管接关以及皮肤消毒的应用,主要从国际及国内的标准与规范及循证文献进行阐述。
2002年|Hibbard等认为,2%葡萄糖酸氯已定醇消毒液与70%异丙醇、2%葡萄糖酸氯已定相比,24小时后人体腹部的菌落数与基线相比明显减少,显示更强的持续残留活性,且所有消毒剂都无刺激性。
2%葡萄糖酸氯已定醇消毒液与70%异丙醇、2%葡萄糖酸氯已定及10%聚维酮碘相比,其长效性和快速杀菌能力均更具优势。
2006年|Menyhay等开展了一项前瞻性模拟实验室研究,对照70%乙醇和70%乙醇葡萄酸氯己定消毒剂用于无针接头的消毒效果。
结果显示:未进行消毒直接连接的15个接头100%细菌传播(4500-10000 CFU),30个使用70%乙醇消毒的接头20个(67%)细菌传播(442-25000 CFU),60个使用含70%乙醇葡萄酸氯己定的消毒的接头只有1个接头有(1.6%)细菌传播。
2007年|Casey等进行了一项研究,观察导管接头使用70%乙醇和3.15%氯己定醇的消毒效果。
结果显示,所有未消毒的接头细菌生长(金黄色葡萄球菌400-500 CFU、表皮葡萄球菌400-500 CFU、铜绿假单胞菌50-100 CFU),使用70%乙醇和3.15%氯己定醇消毒应用摩擦力擦拭15s无细菌生长。
2009年|James Soothill发表了一篇《2%葡萄糖酸氯已定醇消毒导管接头降低导管相关血流感染》的文章,这个研究的概况如下:目的是验证2%葡萄糖酸氯已定醇消毒擦片是否能降低导管相关血流感染。
chlorohexidine gluconate bathingimpregnated cloths results insignificant reduction inline-associated bloodstreamM.Dixon,RN,BSN,MHA,CCRN,CIC,and Robin L.Carver,RN,BSN,CICRaleigh,North CarolinaBackground:Central line-associated bloodstream infections(CLABSI)contribute to increased morbidity,mortality,length of stay, and excessive cost of care.Methods:This study was an observational cohort study using historical controls in the setting of a9-bed surgical intensive care unit in a Level I trauma center;all patients admitted or transferred into the unit were enrolled in the study.Objectives:A quality improvement intervention protocol was instituted to reduce CLABSI incidence with a3-month effectiveness study using2%chlorhexidine gluconate-impregnated cloths for daily patient bathing;education of surgical intensive care unit staff on changes to CLABSI prevention protocol and all existing CLABSI prevention policies and bundles already in place;and com-pliance monitoring and documentation.Results:The3-month effectiveness study showed a decrease in CLABSI rates from12.07CLABSIs per1000central line-days to3.17 CLABSIs per1000central line-days(73.7%rate reduction;P5.0358).Conclusion:CLABSI incidence rates were reduced in a high-risk patient population using evidence-based prevention bundles and implementing daily bathing with2%chlorhexidine gluconate nonrinse cloths.Key Words:CLABSI;bloodstream infection;chlorhexidine;CHG bathing.Copyrightª2010by the Association for Professionals in Infection Control and Epidemiology,Inc.Published by Elsevier Inc.All rights reserved.(Am J Infect Control2010;38:817-21.)The Centers for Disease Control and Prevention de-fines a central line-associated bloodstream infection(CLABSI)as a primary bloodstream infection occurringin a patient with a central line in place within48hoursprior to onset of the infection.1In2008,the NationalHealthcare Safety Network reported a pooled meanincidence rate of CLABSIs in the trauma critical carepatient population of4.0CLABSIs per1000centralline-days.2CLABSIs contribute to patient morbidity and mortality,extended length of stay,and increased cost of care.3-8In-fectious disease and infection prevention professionalsfollow the guidance of national prevention programs toprevent CLABSIs and other hospital-acquired infec-tions.8,9One of the most frequently touted preventiontools is the Institute for Healthcare Improvement(IHI)Central Line Bundle,9which consists of5interventions:(1)hand hygiene;(2)maximal barrier precautions duringinsertion;(3)skin antisepsis with chlorhexidine gluco-nate(CHG);(4)optimal catheter site selection with avoid-ance of the femoral vein for central venous access inadult patients;and(5)daily review of line necessity,with prompt removal of unnecessary lines.The surgical intensive care unit(SICU)in a Level Itrauma center successfully implemented the IHI Cen-tralLine Bundle in2005.By January2007,compliancewith the IHI Central Line Bundle was sustained atgreater than90%,but the unit’s CLABSI rate was trend-ing above the National Healthcare Safety Networkbenchmark rate.A review of the available literatureidentified a study by Bleasdale et al(2007)10in which817a61%decrease in the CLABSI rate occurred in a medical intensive care unit after implementation of daily bathing with CHG-impregnated cloths.The organization’s Infection Prevention and Control De-partment staff decided to attempt to replicate these results in the SICU setting.We worked with the man-agement and staff of the SICU to implement a quality improvement intervention of daily bathing with CHG-impregnated cloths to reduce the incidence of CLABSIs in the SICU.METHODSDesign overviewThis was an observational cohort study that used historical controls.Setting and participantsThe study setting was a9-bed SICU in a Level I trauma center.All patients admitted or transferred into the unit were enrolled in the study.Intervention objectivesThe Institutional Review Board of this organization approved(waiver received)a quality improvement in-tervention protocol with the following objectives:Reduce CLABSI incidence rates in the SICU through an initial3-month effectiveness study of the use of 2%CHG-impregnated cloths for daily patient bathing per a standardized protocol;educate SICU staff about the CLABSI prevention pro-tocol and about all existing CLABSI prevention poli-cies and bundles in place;monitor caregiver compliance using a daily log;compare historical preintervention and postinterven-tion CLABSI rates;andextend the2%CHG bathing protocol predicated on proven effectiveness.Description of usual practicesThe following practices were in place during the ef-fectiveness study:Noncoated,nonantimicrobial central lines were rou-tinely used throughout the facility.Maximal sterile barrier precautions were utilized at time of insertion.A standardized kit is available in the facility.Ports were decontaminated with alcohol prep pads for5seconds prior to access.No securement device was in use.A dressing(Biopatch[ETHICON,INC;a Johnson& Johnson Company,Somerville,NJ]with T egaderm[3M Health Care,St.Paul,MN])was applied at the time of insertion and changed every7days and as needed utilizing aseptic technique according to the facility’s policy,which requires performance of hand hygiene and application of clean gloves prior to changing the dressing.Hand hygiene was utilized,and clean gloves were worn prior to handling any central lines.Alcohol hand gel was available for use before and after pa-tient contact if hands were not visibly soiled;other-wise,soap and water hand hygiene was required. Unit hand hygiene compliance averaged greater than80%throughout the study period.ChloraPrep(Enturia,Inc,Leawood,KS)was utilized for site cleaning at insertion and with dressing changes. Tubing was changed every72hours per Centers for Disease Control and Prevention recommendations. Necessity of lines was reviewed on the daily goals sheet and in interdisciplinary rounds.Whereas lines were usually closed systems,occa-sionally,patients who had certain surgical proce-dures arrived to the unit with a stopcock or other device attached to the line.Blood for laboratory orders was drawn from central lines per physician order.CHG interventionAll SICU patients without a known sensitivity to CHG were bathed daily with disposable2%CHG-impregnated cloths(Sage2%Chlorhexidine Gluconate Patient Preoperative Skin Preparation Cloths;Sage Pro-ducts Inc,Cary,IL).This bath replaced traditional bathing methods using soap and water in a basin.The bath was documented daily on a compliance monitoring log.The cloths were not rewarmed,rewet,rinsed,or reused and were kept in the manufacturer-provided warmer.One pack of6cloths was used for each bath, with1cloth used for each of the following areas:Neck,chest,and arms;back;right leg;left leg;perineum;andbuttocks.The CHG cloths were not used on the head,on the face,or inside the vagina;these areas were cleansed with a terry-cloth washcloth,soap(Aloe Vesta Body Wash&Shampoo;ConvaT ec,Princeton,NJ),and water. Each patient’s skin was moisturized with baby oil or skin conditioner(Lotion Soft Skin Conditioner Skin Cream;STERIS Corp,Mentor,OH).Incontinence cleanup was also performed with a terry-cloth wash-cloth,soap,and water.A pack of2CHG-impregnated818Dixon and Carver American Journal of Infection ControlDecember2010cloths was used after each incontinence cleanup to en-sure the persistent presence of CHG on the skin.Each day,the charge nurse or designee placed a sticker from each patient’s chart on the SICU CHG bath-ing log and checked the box indicating whether or not the patient received the CHG bath that day;if they did not,the reason was provided.Compliance monitoring of central line bundleCompliance with maximal sterile barrier precau-tions at insertion is evaluated through an audit per-formed by nursing staff assisting with central line insertion.Each line inserted is audited,and the audit results charted on a checklist that is not a part of the patient medical pleted central line inser-tion bundle checklists are submitted to the Infection Prevention Department,where they are entered into a database.Data are analyzed by unit,and compliance rates are reported quarterly.Audits of compliance with hand hygiene are con-ducted on a similar checklist.All hand hygiene compli-ance audits are entered into a system-wide database from which unit and system level reports can be ob-tained by unit management staff.Hand hygiene com-pliance data are presented monthly on the unit-based nursing scorecard.Staff educationAll nursing staff members receive education about infection prevention policies and practices on hireand are trained and evaluated on central line practices at the unit level by nurse educators.Clinical perfor-mance is evaluated annually by unit management staff.Documentation of adverse eventsIf a rash or other adverse reaction developed during the study period,caregivers were instructed to discon-tinue the use of the CHG cloths and to resume soap-and-water bathing.Furthermore,the principal in-vestigator for this quality improvement project was to be contacted,and sensitivity to CHG was to be recorded on the patient’s medical record.Data collectionThe CLABSI preintervention and postintervention incidence rates were calculated as follows:(number of CLABSIs/number of central line-days)31000.Statistical analysisHypothesis.We hypothesized that the CLABSI rate in the SICU would decrease at least 30%from the prein-tervention to the postintervention time periods,which were defined as follows:Initial 3-month effectiveness study:May 2008through July 2008;andextended postintervention period:May 2008through September 2009.Sample size.With data from more than 6000device-days,there was adequate statistical power todetectFig 1.CLABSI rate January 2007through September 2009. Vol.38No.10Dixon and Carver 819an absolute difference of less than 1%as statisti-cally significant with an a level of 5%and a b level of 20%.Statistical methods.A x 2test was used to assess the change in CLABSI rates over time.Counts per 1000device-days were presented as the CLABSI rates.In ad-dition,the test statistic and P values were reported,and a P value less than or equal to an a level of.05was con-sidered statistically significant.RESULTSThe initial 3-month effectiveness study included 144patients and showed a decrease in CLABSI rates from 12.07CLABSIs per 1000central line-days to 3.17CLABSIs per 1000central line-days,a 73.7%rate reduction (P 5.0358).On the basis of these results,the protocol of daily bathing with CHG-impregnated cloths was continued,and a comparison was madebetween the CLABSI rates using a preintervention pe-riod of January 2007through April 2008and postinter-vention period of May 2008through September 2009.A statistically significant relative reduction of 76%(test statistic 513.1,P ,.001)was noted,from a pre-intervention CLABSI rate of 8.6CLABSIs per 1000cen-tral line-days (27/3148)to 2.1CLABSIs per 1000central line-days (7/3346)(Fig 1;T able 1).The CHG bathing logs,composed of a simple grid with space for a patient identification sticker and a check box indicating whether or not a CHG bath was given,indicated that compliance with the quality im-provement intervention was 100%.There were no ad-verse events reported for any patient associated with this study.DISCUSSIONPrevention of CLABSIs is a key focus of infection pre-vention professionals.This intervention was imple-mented in a clinical setting where basic infection prevention measures had been successfully imple-mented with high compliance rates,but elevated CLABSI incidence rates persisted.A thorough review of the evidence-based literature indicated that additional measures could be taken to help prevent CLABSIs.The ‘‘Compendium of Strategies to Prevent Healthcare-Associated Infections’’8of the Society for Healthcare Epidemiology of America/Infectious Disease Society of America outlines guidance for preventing CLABSIs,which includes adherence to national guide-lines,such as the IHI Central Line Bundle;existence of appropriate hospital infrastructure,such as staffing,lab-oratory facilities,resources for education,and training;and practical implementation of prevention activities,including physician/nurse education,development of catheter insertion checklists,and establishment of cath-eter insertion kits (ie,all necessary items for catheter in-sertion).The guidance provided by Society for Healthcare Epidemiology of America/Infectious Disease Society of America also includes special approaches recommended for use in locations within the hospital that have unacceptably high CLABSI rates despite im-plementation of the basic CLABSI prevention strategies.One of these recommendations is as follows:‘‘Bathe ICU patients older than 2months of age with a chlorhexi-dine preparation on a daily basis (B-II).’’8In the context of the continued high rate of CLABSI in the SICU,the in-fection prevention and control staff recognized that bathing patients daily with CHG-impregnated cloths should add an additional preventive measure against development of CLABSIs.The results of this study support the findings of other researchers who have reported a decreased incidence of CLABSIs with the use of CHG-impregnated cloths forT able 1.Infection rate and confidence interval per monthMonth-year Infection rate (per 1000device-days)Lower limit of 95%confidence interval Upper limit of 95%confidence interval January-200713.333 2.758138.469February-2007 5.18130.131228.529March-20070.00000.000024.293April-2007 5.52490.139930.397May-2007 4.40530.111524.299June-20079.8522 1.195435.135July-20079.0909 1.102932.452August-2007 5.05050.127927.817September-20070.00000.000023.077October-20070.00000.000018.645November-2007 4.67290.118325.759December-200727.77810.26159.477January-200817.937 4.908445.287February-2008 5.84800.148032.150March-200810.753 1.304938.301April-200810.695 1.297938.099May-20089.7561 1.183734.796June-20080.00000.000017.834July-2008 4.52490.114624.952August-20080.00000.000017.090September-20088.6580 1.050330.924October-2008 4.44440.112524.513November-20080.00000.000019.956December-20080.00000.000017.748January-2009 4.00000.101322.084February-20090.00000.000019.533March-20090.00000.000020.511April-20090.00000.000017.495May-20090.00000.000019.030June-2009 5.84800.148032.150July-20090.00000.000023.369August-20090.00000.000024.454September-20090.00000.000022.242820Dixon and CarverAmerican Journal of Infection ControlDecember 2010daily patient bathing.10,11An estimated 248,678blood-stream infections occur in hospitals each year,12with an estimated mortality rate of 12%to 25%for each CLABSI.The financial burden on the health care system is estimated at $36,441per episode,with an annual eco-nomic expenditure of approximately $9,062,074,998.13Given these cost estimates,this quality improvement initiative resulted in cost savings during the 17-month intervention period of approximately $728,820(from $983,907preintervention [January 2007through April 2008]to $255,087postintervention [May 2008through September 2009])(Fig 2).As with any successful quality improvement initiative,support from the unit’s man-agement staff and ongoing caregiver education were es-sential to ensuring effective compliance.The clinical implications of this study are clear:daily bathing with 2%CHG-impregnated cloths can signifi-cantly reduce the incidence of CLABSIs in a SICU pa-tient population.Unlike many other interventions suggested for CLABSI reduction,CHG cloth bathing does not require additional work on the part of the pa-tient care staff because it replaces an existing bathing process.In fact,anecdotal reports from staff members indicate increased satisfaction with CHG cloth bathing over traditional basin bathing because the rinsing step is eliminated from the bathing process.In addition,re-placement of traditional soap-and-water bathing with 2%CHG cloth bathing may reduce the risk of many types of hospital-acquired infections by eliminating the need for bath basins,a known source of environ-mental microbial contamination.14In clinical areas where basic infection prevention measures have been successfully implemented withhigh compliance rates,alternative methods should be investigated to decrease infection rates.In these situa-tions,implementation of evidence-based quality im-provement initiatives improves patient outcomes.The authors thank the SICU management team and staff for their diligent and enthu-siastic implementation of this quality improvement intervention and their ongoing commitment to infection prevention.References1.Centers for Disease Control and Prevention.NHSN manual:patient safety component protocols.Available from:/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf .Accessed December 7,2009.2.Edwards JR,Peterson KD,Andrus ML,Dudek MA,Pollock DA,Horan TC,et al,The National Healthcare Safety Network Facilities.National Healthcare Safety Network (NHSN)peport,data summary for 2006through 2007,issued November 2008.Am J Infect Control 2008;36:609-26.3.Maki DG,Kluger DM,Crnich CJ.The risk of bloodstream infection in adults with different intravascular devices:a systematic review of 200published prospective studies.Mayo Clin Proc 2006;81:1159-71.4.O’Grady NP ,Alexander M,Dellinger EP ,Gerberding JL,Heard SO,Maki DG,et al.Guidelines for the prevention of intravascular catheter-related infections.Centers for Disease Control and Preven-tion.MMWR Recomm Rep 2002;51(RR-10):1-29.5.Pittet D,T arara D,Wenzel RP .Nosocomial bloodstream infections in critically ill patients:excess length of stay,extra cost,and attributable mortality.JAMA 1994;271:1598-601.6.Hu KK,Veenstra DL,Lipsky BA,Saint e of maximal sterile bar-riers during central venous catheter insertion:clinical and economic outcomes.Clin Infect Dis 2004;39:1441-5.7.Warren DK,Quadir WW ,Hollenbeak CS,Elward AM,Cox MJ,Fraser VJ.Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.Crit Care Med 2006;34:2084-9.8.Marschall J,Mermel LA,Classen D,Arias KM,Podgorny K,Anderson DJ,et al.Strategies to prevent central line-associated bloodstream infec-tions in acute care hospitals.Infect Control Hosp Epidemiol 2008;29(Suppl 1):S22-30.9.5Million Lives Campaign.Getting started kit:prevent central line in-fections how-to guide ( )Cambridge,MA:Institute for Healthcare Improvement;2008.10.Bleasdale SC,T rick WE,Gonzalez IM,Lyles RD,Hayden MK,Weinstein RA.Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients.Arch Intern Med 2007;167:2073-9.11.Holder C,Zellinger M.Daily bathing with chlorhexidine in the ICU toprevent central line-associated bloodstream infections.J Clin Out-comes Manage 2009;16:509-13.12.Klevens RM,Edwards JR,Richards CL Jr,Horan TC,Gaynes RP ,PollockDA,et al.Estimating health care-associated infections and deaths in US hospitals,2002.Public Health Rep 2007;122:160-6.13.Stone PW ,Braccia D,Larson E.Systematic review of economic anal-yses of health care-associated infections.Am J Infect Control 2005;33:501-9.14.Johnson D,Lineweaver L,Maze L.Patients’bath basins as potentialsources of infection:a multicenter sampling study.Am J Crit Care2009;18:31-40.Fig 2.Cost of CLABSI:preintervention andpostintervention. Vol.38No.10Dixon and Carver 821。